What is BioSTL?
BioSTL is a St. Louis-based entity dedicated to cultivating innovation and entrepreneurship, with a pronounced focus on the medical and plant biosciences industries. Through its investment arm, BioGenerator, the organization provides crucial capital, resources, and training to emerging startups. Furthermore, BioSTL's GlobalSTL initiative actively works to attract high-growth international companies, thereby enriching the local innovation economy. The organization's strategic approach emphasizes inclusivity and collaboration, aiming to cultivate a dynamic and globally interconnected innovation landscape within the region.
How much funding has BioSTL raised?
BioSTL has raised a total of $30.4M across 2 funding rounds:
Other Financing Round
$30M
Debt
$350K
Other Financing Round (2011): $30M, investors not publicly disclosed
Debt (2020): $350K led by PPP
What's next for BioSTL?
With a significant enterprise-level funding context, BioSTL is strategically positioned for substantial growth and expansion. The recent major strategic investment signals confidence from stakeholders in its mission to bolster the St. Louis innovation economy. Future endeavors will likely involve further scaling of BioGenerator's investment activities, attracting more international companies through GlobalSTL, and deepening collaborations within the biosciences and medical technology fields. This capital infusion is expected to accelerate the development of new ventures and solidify the region's standing as a hub for bioscience innovation.
See full BioSTL company page
